Minerva Surgical (UTRS) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChart

Minerva Surgical Revenue Highlights


Latest Revenue (Y)

$50.29M

Latest Revenue (Q)

$11.96M

Main Segment (Y)

Warranty Service

Main Geography (Y)

Warranty Service

Minerva Surgical Revenue by Period


Minerva Surgical Revenue by Year

DateRevenueChange
2022-12-31$50.29M-3.47%
2021-12-31$52.10M37.96%
2020-12-31$37.77M45.19%
2019-12-31$26.01M-

Minerva Surgical generated $50.29M in revenue during NA 2022, up -3.47% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Minerva Surgical Revenue by Quarter

DateRevenueChange
2023-09-30$11.96M-10.65%
2023-06-30$13.39M6.85%
2023-03-31$12.53M-9.21%
2022-12-31$13.80M9.66%
2022-09-30$12.59M-2.92%
2022-06-30$12.97M18.58%
2022-03-31$10.94M-19.86%
2021-12-31$13.64M9.11%
2021-09-30$12.51M-11.39%
2021-06-30$14.11M19.23%
2021-03-31$11.84M-12.63%
2020-12-31$13.55M10.33%
2020-09-30$12.28M-

Minerva Surgical generated $11.96M in revenue during Q3 2023, up -10.65% compared to the previous quarter, and up 92.27% compared to the same period a year ago.

Minerva Surgical Revenue Breakdown


Minerva Surgical Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 21
Warranty Service$100.00K

Minerva Surgical's latest annual revenue breakdown by segment (product or service), as of Dec 21: Warranty Service (100.00%).

Minerva Surgical Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 21
Warranty Service$100.00K

Minerva Surgical's latest annual revenue breakdown by geography, as of Dec 21: Warranty Service (100.00%).

Minerva Surgical Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
UTRSMinerva Surgical$50.29M$11.96M
AKANAkanda$2.16M$762.61K
SQLSeqLL$1.18K-
HILSTharimmune--
DRMADermata Therapeutics--
RNAZTransCode Therapeutics--

UTRS Revenue FAQ


Minerva Surgical's yearly revenue for 2022 was $50.29M, representing a decrease of -3.47% compared to 2021. The company's yearly revenue for 2021 was $52.1M, representing an increase of 37.96% compared to 2020. UTRS's yearly revenue for 2020 was $37.77M, representing an increase of 45.19% compared to 2019.

Minerva Surgical's quarterly revenue for Q3 2023 was $11.96M, a -10.65% decrease from the previous quarter (Q2 2023), and a -4.95% decrease year-over-year (Q3 2022). The company's quarterly revenue for Q2 2023 was $13.39M, a 6.85% increase from the previous quarter (Q1 2023), and a 3.27% increase year-over-year (Q2 2022). UTRS's quarterly revenue for Q1 2023 was $12.53M, a -9.21% decrease from the previous quarter (Q4 2022), and a 14.61% increase year-over-year (Q1 2022).

Minerva Surgical's revenue growth rate for the last 3 years (2020-2022) was 33.17%

Minerva Surgical's revenue streams in c 21 are Warranty Service

For the fiscal year ending Dec 21, the largest source of revenue of Minerva Surgical was Warranty Service. This segment made a revenue of $100K, representing 100.00% of the company's total revenue.